Streetbeat News

Stock Prices

HLNE

The options market is indicating potential significant movements in Hamilton Lane (HLNE) stock, suggesting investors should monitor it closely.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

BMRN

The options market is indicating potential significant movements in BioMarin Pharmaceutical (BMRN) stock, suggesting investors should closely monitor this asset.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

MBIN

Johnson Fistel, LLP is investigating Merchants Bancorp (NASDAQ: MBIN) for potential securities law violations related to misrepresentation or nondisclosure of information, which may have led to investor losses.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

MU

Micron Technology's stock fell after its FQ1 2025 earnings report, which showed mixed results and guidance. Despite near-term weakness, the company's shift towards AI suggests long-term strength.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

BAC

C

CMA

JPM

KEY

The Federal Reserve has signaled fewer rate cuts for 2025 due to persistent inflation, which suggests a challenging operating environment for banks such as JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Comerica (CMA), and KeyCorp (KEY).

Portfolio Pulse from

December 19, 2024 | 3:00 pm

ABCB

Ameris Bancorp has announced a 33.3% increase in its quarterly dividend, raising it to 20 cents per share. This decision is supported by the company's strong liquidity and capital position, which will help sustain these capital distributions.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

TD

A class action lawsuit has been filed against The Toronto-Dominion Bank (NYSE:TD) for potential securities law violations. Investors who suffered losses are encouraged to join the suit by December 21, 2024.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

IMMX

Immix Biopharma announced positive clinical data from the NEXICART-2 U.S. trial for their CAR-T therapy, NXC-201, in treating relapsed/refractory AL Amyloidosis. All four patients showed normalized disease markers, with two achieving complete response and two being bone marrow MRD negative.

Portfolio Pulse from

December 19, 2024 | 2:45 pm

TSLA

Tesla's stock recently dropped 8.3% to $440.12 amid a broader market selloff, with the Nasdaq Composite and S&P 500 also declining. Despite this, there is speculation that Tesla's stock could reach $1000 by the end of 2025.

Portfolio Pulse from

December 19, 2024 | 2:45 pm

AVGO

MU

NVDA

The article discusses the competitive landscape in the semiconductor industry, highlighting the challenges faced by Micron Technology (MU) due to increasing competition from Broadcom (AVGO) and NVIDIA (NVDA). Kim Forrest notes that AI remains a strong growth area.

Portfolio Pulse from

December 19, 2024 | 2:45 pm